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INTRODUCTION: Evaluation of pre- and postoperative serum CEA levels together has seldom been assessed for the prognosis 
of colorectal cancer (CRC). 
OBJECTIVE: To concurrently evaluate pre- and postoperative CEA as factors of relapse and survival. 
METHODS: The study consisted of 114 patients who had undergone surgery from February 2002 to June 2006 for CRC. All 
patients were classified into four groups according to their pre- and postoperative CEA levels. Data obtained for clinicopathologic 
parameters, lymph node metastasis, stage, recurrence, and CEA levels were analyzed to determine their association with survival. 
Multivariate analysis by the Cox proportional hazard regression model was performed to identify the independent prognostic fac-
tors associated with survival. 
RESULTS: Postoperative serum CEA levels remained high in Group 3 (n = 32). Nineteen patients (59.3%) demonstrated a de-
tectable cause for persistent high CEA levels, while the reasons for those in the other thirteen patients (40.6%) remained obscure. 
Abnormal preoperative CEA levels significantly correlated with the depth of tumor invasion, lymph node metastasis, TNM stage, 
and recurrence (p < 0.05). Abnormal postoperative CEA levels were significantly related to the depth of tumor invasion, TNM 
stage, and postoperative relapse (p<0.05). Patients in Group 3 demonstrated the worst survival rate. Abnormal postoperative CEA 
levels, lymph node metastasis, and location of the tumor were independent prognostic factors for survival. 
CONCLUSION: The survival of patients with high postoperative CEA levels due to unknown reasons may be extended if they 
are exhaustively tested with sensitive diagnostic methods and treated at an early stage. 
KEYWORDS: Colorectal cancer; Carcinoembryonic antigen; Recurrence; Survival; Prognosis. 
INTRODUCTION
Colorectal cancer (CRC) is a very serious health problem 
worldwide and is a leading cause of morbidity and mortality 
due to cancer.1 The best prognostic factor for these patients is 
tumor node metastasis (TNM) classification.2 However, there 
are some difficulties in obtaining the data preoperatively. 
Therefore, a search for preoperative prognostic parameters 
may be important for assessing the outcome of CRC patients. 
Carcinoembryonic antigen (CEA) is the most commonly 
studied tumor marker in CRCs.3 The clinical significance 
of CEA in CRC patients has been well investigated, and 
elevated preoperative serum CEA levels have been associated 
with advanced tumor stage4-7 The prognostic significance of 
postoperative serum CEA levels or the evaluation of both 
pre- and postoperative serum CEA levels have seldom been 
discussed. The importance of this tumor marker in relapse 
and survival of CRC patients has rarely been explored. The 
aim of this retrospective study was to evaluate the value of 
pre-and postoperative CEA concurrently as a significant 
factor in the relapse and survival of CRC patients. 
MATERIALS AND METHODS
The medical records of 151 patients with colorectal 
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carcinoma that were admitted to our department from 
February 2002 until June 2006 were reviewed. Of the 
151 patients, 27 stage IV patients were excluded from 
the analysis. Patients who had undergone neoadjuvant 
chemotherapy and/or radiotherapy, patients with a known 
second neoplastic disease, and patients with clinically or 
pathologically confirmed abnormal liver function or liver 
cirrhosis were also excluded. An additional 10 patients were 
lost during follow-up. Finally, 114 patients who underwent 
curative surgical treatment for primary lesions and who had 
Stage I-III diseases were included in the study. Curative 
surgical treatment was defined as any gross residual tumor 
that did not remain in the surgical bed and a surgical 
resection margin that was pathologically negative for tumor 
invasion. Patients were staged according to the criteria of the 
American Joint Commission on Cancer (AJCC).8 
All 114 patients were categorized into four groups 
according to pre- and postoperative CEA levels: Group 1 
(n= 45) comprised patients with both pre- and postoperative 
serum CEA levels < 5 ng/ml; Group 2 (n= 22) comprised 
patients with preoperative serum CEA levels < 5 ng/ml 
and postoperative serum CEA levels ≥ 5 ng/ml; Group 3 
(n= 32) included patients with both pre- and postoperative 
serum CEA levels ≥ 5 ng/ml; Group 4 (n=15) consisted of 
patients with preoperative serum CEA levels ≥ 5 ng/ml and 
postoperative serum CEA levels < 5 ng/ml. 
Thirty-two patients presented high postoperative serum 
CEA levels. We divided these patients into two groups and 
analyzed each according to known and unknown causes of 
high serum CEA after surgery. The first group consisted 
of 13 patients (40.6%) with an undetermined cause of 
high CEA, and the other 19 patients (59.3%) had a known 
cause of high preoperative CEA. Additionally, patients with 
unknown causes were compared with those whose CEA 
levels decreased to within normal ranges (< 5 ng/ml) after 
surgery. 
Detection of serum CEA
Blood samples were obtained 1 week before and 4 
weeks after surgery. Serum CEA levels were determined 
by an enzyme immunoassay test kit (DPC Diagnostic 
Product Co., Los Angeles, CA, USA) with the upper limit of 
normal defined as 5 ng/ml according to the manufacturer’s 
instructions. 
Statistical Analyses
All data were analyzed using the Statistical Package 
for the Social Sciences Version 13.0 software (SPSS 
Inc., Chicago, III., USA). The χ2 test was used to compare 
clinicopathologic parameters between groups and pre- and 
postoperative serum CEA levels. Multivariate analysis of 
independent prognostic factors for postoperative relapse 
was determined using logistic regression analysis. The 
cumulative survival rates were calculated by the Kaplan-
Meier method, and differences in survival rates were 
analyzed by the log-rank test. A multivariate analysis of 
independent prognostic factors for survival was determined 
using the Cox proportional hazards model. A value of p < 
0.05 was considered as statistically significant. 
RESULTS
The patients had a median age of 73.5 ± 12.08 (range 
24-92 years), and included 70 (61.4%) men and 44 (38.6%) 
women. The location of the primary lesion was the colon in 
67 (58.7%) patients, and the rectum in 47 (41.3%). Twenty-
four (21.2%) patients were stage I, 49 (42.9%) were stage 
II, and 41 (35.9%) were stage III. Histologic tumor types 
were as follows: 15 (13.1%) were well-differentiated, 88 
(77.1%) were moderately-differentiated, and 11 (9.8%) were 
poorly-differentiated colorectal carcinomas. The follow-up 
was completed in March 2008, with a median follow-up 
period of 45 months (range 21 - 73 months). Forty-four 
patients (38.5%) had a postoperative relapse due to either a 
local recurrence (8 patients / 18%) or a distant metastasis (36 
patients / 82%). Among the 44 patients with postoperative 
relapse, 30 (68.1%) died. Among the 36 patients with distant 
metastasis, 17 (47.2%) were colon and 19 (52.8%) were 
rectal cancers. The other 3 colon cancer and 5 rectal cancer 
patients demonstrated a local recurrence. 
The characteristics of the CRC patients are summarized 
in Tables 1 and 2. Forty-seven patients (41.2%) displayed 
abnormal preoperative serum CEA levels, and 54 (47.3%) 
had abnormal postoperative serum CEA levels. Among 
the patients with abnormal preoperative serum CEA, the 
levels remained high for 32 (68%) patients, despite surgical 
resection. Among the patients with normal preoperative 
serum CEA levels, 22 patients (22/67 32.8%) exhibited 
abnormal postoperative serum CEA levels at the time of 
follow-up. 
Preoperative serum CEA levels correlated significantly 
with the depth of tumor invasion (p=0.041), lymph 
node metastases (p= 0.022), TNM stage (p= 0.002), and 
postoperative relapse (p= 0.018). Age, gender, tumor size, 
histologic type, and primary sites of the tumor (colon versus 
rectum) were not significant. Colorectal patients with 
abnormal postoperative serum CEA levels demonstrated a 
significant association with gender (p=0.02), depth of tumor 
invasion (p= 0.015), advanced TNM stage (p=0.037), and 
recurrence (p= 0.005). 
289
CLINICS 2009;64(4):287-94 Persistent high postoperative carcinoembryonic antigen in colorectal cancer patients- is it important?
Filiz AI et al.
Among the 32 patients whose postoperative serum 
CEA levels remained high, the cause was unknown for 13 
patients (40.6%) and known for 19 (59.3%) according to 
the findings of surgical exploration (Table 3). Statistical 
analysis demonstrated that clinicopathologic characteristics 
and overall survival rates were not significantly different 
between the two groups (p > 0.05) (Figure 1). There was also 
no significant difference between patients with an unknown 
cause of high CEA levels (n=13) and those whose levels 
returned to normal values after surgery (n=15). There was 
no significant association between demographics and clinical 
features (p > 0.05) (Table 4). However, the overall survival 
rate was significantly different (p = 0.001), and patients with 
normal postoperative serum CEA levels demonstrated better 
survival than the patients whose serum CEA levels remains 
high because of unknown causes (Figure 2). 
Postoperative serum CEA levels (p=0.02), lymph node 
metastases (p=0.0001), and primary tumor sites (p=0.01) were 
Table 1 - Characteristics of patients with low and high CEA 
levels
Preoperative CEA levels
p≥ 5 ng/ml 
(n = 47)
< 5 ng/ml 
(n = 67)
Age
    < 60 years 5 7 0.89
    ≥ 60 years 42 60
Gender 
    Male 27 43 0.46
    Female 20 24
Tumor size  (cm) 
    < 5 cm 20 38 0.16
    ≥ 5 cm 27 29
Primary tumor location
    Colon 30 37 0.35
    Rectum 17 30
Histologic differentiation
    Well 4 11 0.053
    Moderate 35 53
    Poor 8 3
Depth of tumor invasion
    T1 2 4 0.017*
    T2 2 18
    T3 40 41
    T4 3 4
Lymph node metastases
    N0 24 48 0.041*
    N1 13 14
    N2 10 5
TNM Staging system
    I 3 21 0.01*
    II 22 27
    III 22 19
Postoperative relapse
    Absent 18 25 0.018*
    Present 23 22
Table 2 - Demographic and clinical features, and postop-
erative CEA levels of patients with abnormal preoperative 
CEA levels
Postoperative CEA levels
P≥ 5 ng/ml 
(n = 32)
< 5 ng/ml 
(n = 15)
Age
    < 60 years 3 2 0,69
    ≥ 60 years 29 13
Gender 
    Male 22 5 0,02*
    Female 10 10
Tumor size (cm) 
    < 5 cm 13 7 0,70
    ≥ 5 cm 19 8
Primary tumor location
    Colon 20 10 0,78
    Rectum 12 5
Histologic differentiation
    Well 2 2 0,15
    Moderate 23 12
    Poor 7 1
Depth of tumor invasion
    T1 0 2 0,015*
    T2 1 1
    T3 28 12
    T4 3 0
Lymph node metastases
    N0 15 9 0,23
    N1 10 5
    N2 7 1
TNM Staging system
    I 0 3 0,037*
    II 15 7
    III 17 5
Postoperative relapse
    Absent 8 10 0,005*
    Present 24 5
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identified as independent prognostic factors for recurrence by 
multivariate logistic regression analysis (Table 5). Patients 
with abnormal postoperative serum CEA levels exhibited 
a relative risk of 4.050 for postoperative relapse compared 
to patients with normal postoperative serum CEA levels. In 
addition, lymph node metastases and primary tumor sites 
demonstrated a relative risk of 3.769 and 3.342 for recurrence, 
respectively. Abnormal postoperative serum CEA levels were 
the only significant prognostic factor for survival according to 
Cox regression analysis (p=0.0001) (Table 6). 
The overall survival rate for all groups is shown in Figure 
3. Patients in groups 1 and 4 displayed significantly better 
survival rates than patients in groups 2 and 3 (p<0.0001). 
Patients in group three (both pre- and postoperative serum 
CEA levels ≥ 5 ng/ml) demonstrated the worst survival rate 
among all groups (p<0.0001). 
DISCUSSION
Carcinoembryonic antigen was first described in 1965 by 
Table 3 - Demographic and clinical features and their cause-
related association in patients with abnormal postoperative 
serum CEA levels
High postoperative serum CEA levels (≥ 5 ng/ml)
Unknown cause 
(n=13)
Known cause 
(n=19) p
Age
    < 60 years 1 2 0,79
    ≥ 60 years 12 17
Gender 
    Male 10 12 0,43
    Female 3 7
Tumor size (cm) 
    < 5 cm 8 8 0,29
    ≥ 5 cm 5 11
Primary tumor location
    Colon 7 13 0,41
    Rectum 6 6
Histologic differentiation
    Well 0 2 0,98
    Moderate 11 12
    Poor 2 5
Depth of tumor invasion
    T1 0 0 0,41
    T2 1 0
    T3 11 17
    T4 1 2
Lymph node metastases
    N0 5 10 0,14
    N1 3 7
    N2 5 2
TNM Staging system
    I 0 0 0,44
    II 5 10
    III 8 9
Postoperative relapse
    Absent 7 11 0,83
    Present 6 8
Figure 1 - Comparison of survival among patients with abnormal postopera-
tive serum CEA levels
Figure 2 - Overall survival rates comparing patients whose serum CEA 
levels remained high for unknown reasons and those whose levels returned 
to normal after surgery
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Gold and Freedman, and it has been the most investigated 
tumor marker in CRC patients1,9. Preoperative serum CEA 
levels have been widely used to evaluate tumor extension 
and outcome, and postoperative serum CEA levels have 
been correlated with recurrence. Many studies have shown 
that high preoperative levels are associated with poor 
prognosis.3,4,10,11 Similarly, some authors have reported that 
high postoperative CEA is an indicator of recurrence.12,13 
However, the importance of abnormal preoperative serum 
CEA levels has rarely been investigated. In some patients, 
high preoperative CEA fails to return to normal levels 
after successful surgical resection. Therefore, the present 
study was performed to evaluate the correlation of pre- 
and postoperative serum CEA levels with recurrence and 
survival. 
In many instances, the precise reasons for persistent 
high serum CEA levels cannot be determined. The possible 
causes for this failure include overlooked metastases 
or inadequate surgery2 However, smoking habits, renal 
insufficiency, or chronic pulmonary or liver diseases may 
also contribute to this condition.1,2,21 In the present study, the 
cause of high serum CEA levels was unknown for almost 
28% of the patients with persistent, high postoperative CEA 
levels. Although preoperative routine diagnostic methods 
Figure 3 - Comparison of survival for groups 1-4
Table 4 - Comparison of characteristics in patients with 
abnormal preoperative serum CEA levels 
Unknown cause 
of postoperative 
high CEA (n=13)
Postoperative normal 
CEA (convert to 
normal) (n=15)
p
Age
    < 60 years 1 2 0.64
    ≥ 60 years 12 13
Gender 
    Male 10 5 0.02
    Female 3 10
Tumor size (cm) 
    < 5 cm 8 7 0.45
    ≥ 5 cm 5 8
Primary tumor 
location
    Colon 7 10 0.51
    Rectum 6 5
Histologic diffe-
rentiation
    Well 0 2 0.17
    Moderate 11 12
    Poor 2 1
Depth of tumor 
invasion
    T1 0 2 0.15
    T2 1 1
    T3 11 12
    T4 1 0
Lymph node 
metastases
    N0 5 9 0.08
    N1 3 5
    N2 5 1
TNM Staging 
system
    I 0 3 0.05
    II 5 7
    III 8 5
Postoperative 
relapse
    Absent 7 5 0.29
    Present 6 10
Table 5 - Multivariate analysis of factors releated to recurrence in CRC patients 
b SE OR P
95% CI
Lower Upper
Lymph node metastasis (N1+N2 / N0) 1.327 0.367 3,342 0.0001 1,836 7,738
Primary site of tumor (colon or rectum) 1.207 0.466 3, 769 0.01 1,342 8,325
Postoperative CEA levels (≥ 5 ng/ml / < 5 ng/ml) 1.399 0.453 4,050 0.002 1,667 9,841
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(abdominal ultrasonography and abdominal computerized 
tomography) were used to detect metastases, intra-abdominal 
metastatic lesions were detected during surgery in 19 
patients. We conclude that these lesions could explain the 
reason for the observed high CEA levels, but the failure of 
these levels to return to normal in patients with undetectable 
pre- or postoperative lesions remains unclear. Further 
investigation using techniques such as Positron Emission 
Tomography might be a logical next step to determine the 
source of high postoperative serum CEA levels in some 
cases. The survival analysis indicated there is no significant 
difference between patients with known and unknown causes 
of high CEA levels, but patients whose CEA successfully 
returned to normal levels clearly demonstrated a better 
survival rate. 
There are reports indicating that clinicopathological 
features, including gender, tumor depth, and lymph node 
metastasis, influence postoperative CEA levels.14,15 In 
contrast, other reports have demonstrated that gender is not 
a significant factor for CEA levels. In the present study, 
abnormal postoperative CEA levels were significantly more 
common in male patients. However, we could not conclude 
that gender predicted the persistence of high postoperative 
CEA because the number of patients analyzed was limited.
Pathological stage plays the most important role in the 
prognosis of CRC patients16. The committee of the College 
of American Pathologists Consensus Conference stated in 
1999 that the TNM categories and stage subgroups have 
clinical value in prognosis.17 They also recommended 
assessing preoperative CEA levels for prognosis of the 
category I group. Among other suggested prognostic factors 
for category I, preoperative serum CEA was the only factor 
not included in the AJCC staging system.16 According to 
guidelines of the European Group on Tumor Markers, CEA 
is considered to possess independent prognostic value.18 The 
present study included a correlation between abnormal pre- 
and postoperative serum CEA levels with AJCC stages. As 
in other reports, advanced stage significantly correlated with 
higher pre – and postoperative CEA levels. We and many 
other investigators suggest that serum CEA levels should be 
added to the current staging system.7,15,19,20 
In one study, the presence of lymph node metastasis 
correlated with CEA levels;2 however, this finding was not 
apparent in our study due to the presence of patients with 
lymph node metastases. 
Carcinoembryonic antigen is widely used in the 
postoperative course of patients with CRC.22 A high 
concentration of postoperative serum CEA during follow-
up predicts an adverse outcome.23 Early detection of CRC 
relapse is an important factor in reducing cancer mortality.24 
The level of postoperative CEA has been shown to correlate 
with metastasis and local recurrence.25,26 Carcinoembryonic 
antigen has shown promise as an indicator of residual disease 
before recurrence becomes clinically apparent, and patients 
with recurrence might be cured if the residual disease were 
identified and treated effectively at an earlier time. Studies 
have reported that in 18-75% of cases with CRC relapse, 
there is a rise in postoperative CEA levels prior to clinically 
observable recurrence.25,27 This rise has been reported as 
early as 4 months prior to recurrence,28 should aware for 
the potential of recurrence and it is also possible to detect 
the relapse at an early stage. In the present study, 12 of 22 
patients (54%) with increased CEA values after surgery had 
metastases confined to the liver, lung, or locoregional areas 
that were detected within the first 2 years of diagnosis. 
There are other factors that affect postoperative serum 
CEA concentrations in CRC patients. Serum CEA may be 
increased in epithelial tumors at other sites (both benign 
or malignant) in inflammatory bowel disease, pancreatitis, 
liver disease, pulmonary infection, in the presence of bowel 
obstruction, and in persons who smoke.22 In the present 
study, patients with a known second neoplastic disease 
and with abnormal liver function were excluded from the 
study. However, there were patients with postoperative 
complications, such as pulmonary disorders (including 
pneumonia, pleural effusion, atelectasia), toxic hepatitis and 
abnormal renal functions due to anesthesia, and mechanical 
or paralytic bowel obstruction caused by surgery. These 
causes may be responsible for a postoperative increase 
in serum CEA in patients that did not demonstrate local 
recurrence or metastasis. We conclude that patients with 
high CEA concentrations after surgery should be thoroughly 
studied with the understanding that elevated CEA often, but 
not always, predicts the recurrence of CRC. 
Goldstein et al. stated that a failure to return to normal 
CEA levels after surgery is indicative of systemic disease.29 
Table 6 - Multivariate analysis of factors releated to survival in CRC patients
b SE OR P
95% CI
Lower Upper
Postoperative CEA levels (≥ 5 ng/ml / < 5 ng/ml) -1.206 0.216 0.299 0.0001 0.196  0.457
Preoperative CEA levels (≥ 5 ng/ml / < 5 ng/ml) - 0.025 0.165 0.975 0.878 0.706 1.346
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Slentz et al. suggested that if initially elevated serum CEA 
levels remain high after surgery, they may be an indicator 
of increased risk30. Our study demonstrated a better overall 
survival rate for groups 1 and 4 compared to the other 
groups. The present trial demonstrated that patients with 
high preoperative postoperative CEA levels exhibit poorer 
outcome. Moreover, the multivariate analysis indicated 
that abnormal postoperative serum CEA levels, lymph 
node metastases, and the primary tumor site are predictive 
factors for recurrence. Postoperative CEA was the most 
predictive factor for recurrence, with a relative risk of 
4.050. Furthermore, the postoperative serum CEA level was 
the only predictive factor for survival. According to these 
findings, abnormal postoperative serum CEA levels, lymph 
node metastases, and the primary tumor site are independent 
prognostic factors for postoperative surveillance. In our 
opinion, CRC patients with abnormal postoperative serum 
CEA levels should be followed-up for extensive analysis and 
should, potentially, receive adjuvant chemotherapy.
CONCLUSION
Persistent high levels of postoperative serum CEA levels 
are a clinically important predictor of poor prognosis. The 
presence of such levels is an effective measurement of 
therapy after curative resection. Surveillance of patients 
with high postoperative serum CEA with an unknown cause 
should be extended, and these patients should be examined 
with sensitive diagnostic methods and should, potentially, be 
treated for recurrence at an earlier stage of disease. 
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